Free Radic Biol Med 124:541549 Li CK, Baker K, Jones T, Coulson E, Roberts A, Birrell F (2021a) Safety and tolerability of subcutaneous methotrexate in routine clinical practice
Knowing the basics puts their effects in context and makes it easier to see how they fit into the bigger picture of health and weight management
The FDA added it to injectable semaglutide in January 2025, and it climbs the dose axis like everything else. Burning or tingling skin tracks the dose, not the weight lost, and an active-comparator study put the risk about twice that of another weight-loss drug. The mechanism is unsettled: the tempting "it is the drugs signaling arm" story is ruled out, because the strongest GLP-1 signaler in the class carries no such signal
Many patients report fewer cravings, especially for high-calorie foods
Discovery of small-molecule inhibitors selectively targeting the DNA-binding domain of the human androgen receptor
BPC 157 can aid in faster recovery from exercise, support joint health, and enhance overall physical performance
